Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1976 Apr 24;1(6016):992–994. doi: 10.1136/bmj.1.6016.992

Prevention of postoperative deep vein thrombosis with dipyridamole and aspirin.

J T Renney, E F O'Sullivan, P F Burke
PMCID: PMC1639649  PMID: 773495

Abstract

One hundred and sixty patients have been studied in a controlled trial of two drugs which have been in combination to prevent postoperative-deep-vein thrombosis. Both the drugs, dipyridamole (Persantin) and aspirin, were given by mouth from the evening before operation and for seven days after operation. The radioactive fibrinogen test was used to diagnose thrombosis. Of the 85 patients in the control group 24 developed thrombosis (28%). Twelve out of 85 patients (14%) in the test group were found to have thrombosis. Similar significant differences in incidence were found in the various subgroups.

Full text

PDF
992

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Browse N. L., Hall J. H. Effect of dipyridamole on the incidence of clinically detectable deep-vein thrombosis. Lancet. 1969 Oct 4;2(7623):718–720. doi: 10.1016/s0140-6736(69)90429-2. [DOI] [PubMed] [Google Scholar]
  2. Bygdeman S., Eliasson R., Johnson S. Relationship between postoperative changes in adenosine-diphosphate induced platelet adhesiveness and venous thrombosis. Lancet. 1966 Jun 11;1(7450):1301–1302. doi: 10.1016/s0140-6736(66)91205-0. [DOI] [PubMed] [Google Scholar]
  3. Effect of aspirin on postoperative venous thrombosis. Report of the Steering Committee of a trial sponsored by the Medical Research Council. Lancet. 1972 Sep 2;2(7775):441–445. [PubMed] [Google Scholar]
  4. Emmons P. R., Harrison M. J., Honour A. J., Mitchell J. R. Effect of dipyridamole on human platelet behaviour. Lancet. 1965 Sep 25;2(7413):603–606. doi: 10.1016/s0140-6736(65)90515-5. [DOI] [PubMed] [Google Scholar]
  5. Evarts C. M., Alfidi R. J. Thromboembolism after total hip reconstruction. Failure of low doses of heparin in prevention. JAMA. 1973 Jul 30;225(5):515–516. [PubMed] [Google Scholar]
  6. Flanc C., Kakkar V. V., Clarke M. B. The detection of venous thrombosis of the legs using 125-I-labelled fibrinogen. Br J Surg. 1968 Oct;55(10):742–747. doi: 10.1002/bjs.1800551007. [DOI] [PubMed] [Google Scholar]
  7. Gallus A. S., Hirsh J., Tutle R. J., Trebilcock R., O'Brien S. E., Carroll J. J., Minden J. H., Hudecki S. M. Small subcutaneous doses of heparin in prevention of venous thrombosis. N Engl J Med. 1973 Mar 15;288(11):545–551. doi: 10.1056/NEJM197303152881103. [DOI] [PubMed] [Google Scholar]
  8. Harker L. A., Slichter S. J. Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves. N Engl J Med. 1970 Dec 10;283(24):1302–1305. doi: 10.1056/NEJM197012102832402. [DOI] [PubMed] [Google Scholar]
  9. Kakkar V. V., Field E. S., Nicolaides A. N., Flute P. T. Low doses of heparin in prevention of deep-vein thrombosis. Lancet. 1971 Sep 25;2(7726):669–671. doi: 10.1016/s0140-6736(71)92244-6. [DOI] [PubMed] [Google Scholar]
  10. Kakkar V. V., Howe C. T., Flanc C., Clarke M. B. Natural history of postoperative deep-vein thrombosis. Lancet. 1969 Aug 2;2(7614):230–232. doi: 10.1016/s0140-6736(69)90002-6. [DOI] [PubMed] [Google Scholar]
  11. Kakkar V. V., Howe C. T., Nicolaides A. N., Renney J. T., Clarke M. B. Deep vein thrombosis of the leg. Is there a "high risk" group? Am J Surg. 1970 Oct;120(4):527–530. doi: 10.1016/s0002-9610(70)80023-x. [DOI] [PubMed] [Google Scholar]
  12. Kakkar V. V., Nicolaides A. N., Renney J. T., Friend J. R., Clarke M. B. 125-I-labelled fibrinogen test adapted for routine screening for deep-vein thrombosis. Lancet. 1970 Mar 14;1(7646):540–542. doi: 10.1016/s0140-6736(70)90769-5. [DOI] [PubMed] [Google Scholar]
  13. Mustard J. F., Jorgensen L., Hovig T., Glynn M. F., Rowsell H. C. Rôle of platelets in thrombosis. Thromb Diath Haemorrh Suppl. 1966;21:131–158. [PubMed] [Google Scholar]
  14. Mustard J. F., Packham M. A. Factors influencing platelet function: adhesion, release, and aggregation. Pharmacol Rev. 1970 Jun;22(2):97–187. [PubMed] [Google Scholar]
  15. Negus D., Pinto D. J., Brown N. Platelet adhesiveness in postoperative deep-vein thrombosis. Lancet. 1969 Feb 1;1(7588):220–224. doi: 10.1016/s0140-6736(69)91239-2. [DOI] [PubMed] [Google Scholar]
  16. Nicolaides A. N., Kakkar V. V., Renney J. T. Soleal sinuses and stasis. Br J Surg. 1971 Apr;58(4):307–307. [PubMed] [Google Scholar]
  17. O'Brien J. R. The mechanisms of venous thrombosis. Anticoagulants, aspirin, and heparin. Mod Concepts Cardiovasc Dis. 1973 Mar;42(3):11–15. [PubMed] [Google Scholar]
  18. SEVITT S., GALLAGHER N. Venous thrombosis and pulmonary embolism. A clinico-pathological study in injured and burned patients. Br J Surg. 1961 Mar;48:475–489. doi: 10.1002/bjs.18004821103. [DOI] [PubMed] [Google Scholar]
  19. Salzman E. W., Harris W. H., DeSanctis R. W. Reduction in venous thromboembolism by agents affecting platelet function. N Engl J Med. 1971 Jun 10;284(23):1287–1292. doi: 10.1056/NEJM197106102842303. [DOI] [PubMed] [Google Scholar]
  20. Scharrer I., Schepping M., Breddin K. Thromboseprophylaxe mit Aspirin? Der Einfluss von Acetylsalicylsäure auf die Thrombocytenaggregation in vitro und in vivo. Klin Wochenschr. 1969 Dec 15;47(24):1318–1324. doi: 10.1007/BF01484295. [DOI] [PubMed] [Google Scholar]
  21. Sevitt S. Pathology and pathogenesis of deep vein thrombi. Proc R Soc Med. 1975 Apr;68(4):261–261. [PMC free article] [PubMed] [Google Scholar]
  22. Sullivan J. M., Harken D. E., Gorlin R. Pharmacologic control of thromboembolic complications of cardiac-valve replacement. N Engl J Med. 1971 Jun 24;284(25):1391–1394. doi: 10.1056/NEJM197106242842501. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES